ClinicalTrials.Veeva

Menu
A

ACRC Studies | Poway, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Baricitinib
LY3009104
Methotrexate
TAK-079
SEL-212

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Trial sponsors

Lilly logo
Amgen logo
M
S
Sobi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems